Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CNS disorders
CNS disorders
JPM2023: Breakthroughs await, but so do roadblocks
Pharmaphorum
Fri, 01/13/23 - 10:09 am
JPMHC 2023
Inflation Reduction Act
cell therapy
gene therapy
clinical trials
CNS disorders
Lilly's Prevail, Capsida partner to develop gene therapies for nervous system diseases
BioPharma Dive
Wed, 01/4/23 - 05:32 pm
Eli Lilly
gene therapy
Capsida
CNS disorders
Prevail Therapeutics
CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies
MedCity News
Wed, 11/10/21 - 10:17 am
Arbor Biotechnologies
MIT
liver disease
CNS disorders
funding
CRISPR
Ironwood Pharmaceuticals initiates phase 1 trial of IW-6463
Pharmaceutical Business Review
Thu, 01/24/19 - 10:55 am
Ironwood Pharmaceuticals
IW-6463
CNS disorders
clinical trials